Ken Griffin Drug Manufacturers—Specialty & Generic

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Stock List

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$11.8B
$203 Million 0.04% of portfolio
1,764,590
Q3 2024 Added 138.16%
$6.37B
$110 Million 0.02% of portfolio
7,494,299
Q3 2024 Reduced 41.36%
$3.65B
$82.7 Million 0.02% of portfolio
3,155,779
Q3 2024 Added 42.27%
$1.27B
$74 Million 0.01% of portfolio
8,892,293
Q3 2024 Reduced 10.98%
$10.6B
$70.2 Million 0.01% of portfolio
1,158,379
Q3 2024 Reduced 40.99%
$18.9B
$62.5 Million 0.01% of portfolio
3,468,462
Q3 2024 Added 96.13%
$15.9B
$49 Million 0.01% of portfolio
4,222,959
Q3 2024 Added 2,298.44%
$2.96B
$41.9 Million 0.01% of portfolio
5,144,992
Q3 2024 Reduced 27.3%
$960M
$31.6 Million 0.01% of portfolio
529,877
Q3 2024 Added 43.86%
$43.8B
$12.7 Million 0.0% of portfolio
1,204,576
Q3 2024 Reduced 78.68%
$456M
$7.2 Million 0.0% of portfolio
1,068,571
Q3 2024 Added 778.83%
$780M
$6.72 Million 0.0% of portfolio
446,533
Q3 2024 Added 48.81%
$2.16B
$6.56 Million 0.0% of portfolio
135,237
Q3 2024 Reduced 48.61%
$1.07B
$6.38 Million 0.0% of portfolio
142,001
Q3 2024 Added 1.26%
$1.02B
$5.08 Million 0.0% of portfolio
131,344
Q3 2024 Reduced 23.93%
$1.54B
$4.94 Million 0.0% of portfolio
443,261
Q3 2024 Added 33.76%
$1.93B
$3.25 Million 0.0% of portfolio
104,252
Q3 2024 Reduced 27.06%
$789M
$3.24 Million 0.0% of portfolio
1,851,375
Q3 2024 New
$539M
$2.87 Million 0.0% of portfolio
697,426
Q3 2024 Added 70.3%
$708M
$2.45 Million 0.0% of portfolio
151,049
Q3 2024 Added 135.59%
$4.58B
$2.32 Million 0.0% of portfolio
82,924
Q3 2024 Reduced 74.26%
$766M
$2.12 Million 0.0% of portfolio
150,043
Q3 2024 Reduced 64.04%
$4.11B
$1.62 Million 0.0% of portfolio
22,465
Q3 2024 Reduced 77.78%
$760M
$1.13 Million 0.0% of portfolio
511,752
Q3 2024 Reduced 54.96%
$520M
$394,000 0.0% of portfolio
137,854
Q3 2024 Reduced 25.17%
$3.11B
$349,000 0.0% of portfolio
17,889
Q3 2024 Reduced 24.25%
$3.07B
$252,000 0.0% of portfolio
21,249
Q3 2024 New
$265M
$247,000 0.0% of portfolio
46,129
Q3 2024 Added 52.22%
$160M
$220,000 0.0% of portfolio
133,616
Q3 2024 Reduced 91.22%
$443M
$171,000 0.0% of portfolio
20,488
Q3 2024 Reduced 94.08%
$908M
$131,000 0.0% of portfolio
4,287
Q3 2024 Reduced 56.95%
$60M
$101,000 0.0% of portfolio
50,712
Q3 2024 Reduced 1.13%
$1.88B
$100,000 0.0% of portfolio
27,460
Q3 2024 Added 139.95%
$8.46M
$96,000 0.0% of portfolio
26,013
Q3 2024 New
$26M
$92,000 0.0% of portfolio
23,421
Q3 2024 Reduced 77.44%
$217M
$50,000 0.0% of portfolio
10,382
Q3 2024 Added 2.67%
$107M
$12,000 0.0% of portfolio
6,221
Q3 2024 Reduced 76.24%
$0
$4,000 0.0% of portfolio
45,131
Q3 2024 Reduced 33.99%
Filter Shares Options
Ken Griffin

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.
Track Ken Griffin's portfolio
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email